Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014	HAYES, Inc.	Quantitative sensory testing for the diagnosis of lower extremity peripheral neuropathy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intra-aortic balloon pumps for cardiac conditions: guidelines
2014	Malaysian Health Technology Assessment (MaHTAS)	Cone beam computed tomography
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Efficiency of the "housing first" approach for people who are homeless and living with mental illness or with disorders associated to psychoactive substances]
2014	HAYES, Inc.	Recombinant human bone morphogenetic protein (rhBMP) for use in spinal fusion
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Delivery of electroconvulsive therapy in non-hospital settings: a review of the safety and guidelines
2014	New Zealand National Health Committee (NHC)	Varicella and rotovirus vaccination in New Zealand - assessment reports
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Atomoxetine (Strattera®)
2014	HAYES, Inc.	Sex reassignment surgery for the treatment of gender dysphoria
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Update: Cognitive and procedural skills of aging physicians
2014	New Zealand National Health Committee (NHC)	Ischaemic heart disease: a pathway to prioritisation
2014	The Swedish Council on Health Technology Assessment (SBU)	[Drug-eluting stents in coronary arteries]
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Abatacept (Orencia®)
2014	HAYES, Inc.	Total hip replacement with hard on hard prostheses
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Rehydration, anti-diarrheal, and anti-emetic therapy for patients with Ebola virus disease
2014	New Zealand National Health Committee (NHC)	Chronic obstructive pulmonary disease: a pathway to prioritisation
2014	NIHR Health Technology Assessment programme	Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment -systematic review and modelling of progression and cost-effectiveness
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Linaclotide (Constella®)
2014	HAYES, Inc.	Vagus nerve stimulation for epilepsy
2014	NIHR Health Services and Delivery Research programme	Public involvement in research: assessing impact through a realist evaluation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lifestyle prescriptions: a review of the clinical evidence
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Nalmefene (Selincro®)
2014	HAYES, Inc.	Alpha-1 antitrypsin deficiency (AATD)
2014	NIHR Health Services and Delivery Research programme	A systematic review of the effectiveness and cost-effectiveness of peer-based interventions to maintain and improve offender health in prison settings
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Home isolation to prevent tuberculosis transmission: a review of the clinical evidence and guidelines
2014	Malaysian Health Technology Assessment (MaHTAS)	Typhoid carrier test (Typhidot-C)
2014	HAYES, Inc.	Hereditary paraganglioma (PGL)/pheochromocytoma (PCC) syndromes
2014	NIHR Health Services and Delivery Research programme	Targeting the Use of Reminders and Notifications for Uptake by Populations (TURNUP): a systematic review and evidence synthesis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Equipment required for medication nebulization: safety and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to expedite administration of antibiotics
2014	Malaysian Health Technology Assessment (MaHTAS)	Colorec bowel aid with Hai's Perianal Support (HPS)
2014	HAYES, Inc.	HLA-B testing for guidance of treatment with anticonvulsant drugs
2014	NIHR Health Technology Assessment programme	Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Advance care planning in the outpatient oncology setting
2014	Malaysian Health Technology Assessment (MaHTAS)	Antimicrobial dressing with Activated Carbon Fibre (ACF)
2014	NIHR Health Technology Assessment programme	AMIPROM - A randomised controlled trial of amnioinfusion versus expectant management in very early preterm premature rupture of membranes
2014	HAYES, Inc.	miRInform Thyroid
2014	NIHR Health Services and Delivery Research programme	A qualitative study of decision-making and safety in ambulance service transitions
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mobile apps for improving health: clinical evidence
2014	HAYES, Inc.	VeriStrat test to predict response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-manual techniques for room disinfection in healthcare facilities: a review of clinical effectiveness and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Models of physician employment/affiliation after an AMC-Community Hospital merger
2014	HAYES, Inc.	Familial Mediterranean Fever (FMF)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Contact investigations following patient and staff exposure to active tuberculosis infections: a review of the clinical evidence and guidelines
2014	HAYES, Inc.	PCA3 detection test for prostate cancer
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Oral progesterone for the treatment of menopausal symptoms: a review of the clinical evidence
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Management of intraductal papilloma of the breast
2014	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Clinical effectiveness and cost-effectiveness of fissure sealants in children and adolescents with a high caries risk]
2014	HAYES, Inc.	Coflex interlaminar stabilization device (Paradigm Spine LLC) for treatment of lumbar spinal stenosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth: a review of the clinical evidence
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Conceptual models of continuity: current perspectives
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Nab-Paclitaxel (Abraxane®, Ebetaxel®) as first-line therapy for metastatic adenocarcinoma of the pancreas
2014	HAYES, Inc.	Electronic monitoring versus direct observation of hand hygiene compliance in healthcare settings
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Calmare for chemotherapy-induced peripheral neuropathy
2014	NIHR Health Technology Assessment programme	Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Alpharadin, radium-223 Chloride (Xofigo®) for the treatment of patients with symptomatic hormone refractory prostate cancer with skeletal metastases
2014	HAYES, Inc.	Exparel (Bupivacaine liposome injectable suspension; Pacira Pharmaceuticals Inc.) for treatment of postoperative pain
2014	NIHR Public Health Research (PHR) programme	On the buses: a mixed-method evaluation of the impact of free bus travel for young people on the public health
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Closed Intensive Care Units: Clinical and Cost-Effectiveness, Safety, and Guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Supplemental oxygen therapy for patients with acute myocardial infarction
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Bariatric surgery in adolescents with severe obesity
2014	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial
2014	NIHR Health Technology Assessment programme	A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome
2014	HAYES, Inc.	Intron A (Interferon alfa-2b, recombinant; Schering Corp., a Subsidiary of Merck & Co., Inc.) for treatment of bladder cancer
2014	NIHR Public Health Research (PHR) programme	Crime, fear of crime and mental health: Synthesis of theory and systematic reviews of interventions and qualitative evidence
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bariatric surgical procedures for obese and morbidly obese patients: a review of comparative clinical and cost-effectiveness, and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Oral versus intravenous antibiotics for pediatric oncology patients with fever
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Robotically assisted laparoscopic surgery for rectal cancer
2014	The Swedish Council on Health Technology Assessment (SBU)	[Aromatase inhibitors for early-stage breast cancer]
2014	HAYES, Inc.	Living related donor small bowel transplantation for intestinal failure
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Management of geriatric depression identified in the acute care setting
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Left Ventricular Assist Device as permanent support in patients with end-stage heart failure
2014	HAYES, Inc.	NanoKnife System (AngioDynamics Inc.) for irreversible electroporation treatment of pancreatic cancer
2014	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effect of adapted interventions for primary child health care services]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Thromboelastography
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Orthodontic retainers
2014	NIHR Health Technology Assessment programme	Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review
2014	NIHR Health Technology Assessment programme	Preparatory study for the Re-valuation of the EQ-5D Tariff
2014	HAYES, Inc.	NanoKnife System (AngioDynamics Inc.) for irreversible electroporation treatment of primary and metastatic liver tumors
2014	Norwegian Knowledge Centre for the Health Services (NOKC)	Gynecological consequences of female genital mutilation/cutting (FGM/C)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-term use of ondansetron, dolasetron and granisetron for the prevention of nausea and vomiting: a review of the clinical effectiveness and safety
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Impact of physician specialty and hospital models of care on healthcare utilization in patients with sickle cell disease
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Pediatric robotically assisted surgery for pyeoloplasty and fundoplication
2014	HAYES, Inc.	Computerized Neurocognitive Testing (CNT) for sports-related head injury
2014	HAYES, Inc.	Noncontact low-frequency ultrasound using the mist therapy system (Celleration Inc.) for treatment of wounds
2014	Norwegian Knowledge Centre for the Health Services (NOKC)	Immediate health consequences of female genital mutilation/cutting (FGM/C)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to reduce stress among nurses caring for patients with sickle cell disease
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Home-based versus hospital-based supervised exercise or walk advice as treatment for intermittent claudication
2014	NIHR Health Technology Assessment programme	Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation the CASCADE study
2014	NIHR Health Technology Assessment programme	Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study
2014	NIHR Health Technology Assessment programme	A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely specific measures